Table 1 Summary of data/biological sample collection

Clinical Examination

Pain

X

X

X

X

X

X

Tumour Evaluation

X

X

X

X

X

X

X

X

X

X

X

X

Cardiovascular toxicities

X

X

X

X

X

X

X

X

X

X

Second primary tumour

X

X

X

X

X

X

X

X

X

X

Questionnaires

CRF (QLQ-FA12)

X

X

X

X

X

X

X

X

X

X

X

X

X

HRQoL (QLQ-C30/TC26)

X

X

X

X

X

X

X

X

X

X

X

X

X

Cognition (FACT-Cog)

X

X

X

X

X

Anxiety/depression (HADS)

X

X

X

X

X

X

PA/sedentary levels (ONAPS-PAQ)

X

X

X

X

X

X

X

X

X

X

X

X

X

Pain and neuropathies (VAS)

X

X

X

X

X

X

Nutrition (WCRF)

X

X

X

X

X

X

Sustainable return to work

X

X

X

Motivation (EMAPS)

X

X

X

Satisfaction with the connected activity tracker

X

Satisfaction with the intervention

X

Practice locations

X

Physical condition/fitness

6-min walk test

X

X

X

X

X

X

Sit-to-stand test

X

X

X

X

X

X

Handgrip test

X

X

X

X

X

X

Anthropometrics

X

X

X

X

X

X

Number of steps per day (connected activity tracker)

Every day, non-stop (up to M12)

Heart rate (connected activity tracker)

Non-stop (up to M12)

Sleep quality (connected activity tracker)

Non-stop (up to M12)

Gut microbiota study

Blood sampling

X

X

X

X

Optional faecal sampling

X

X

X

X

Blood biomarkers

Gut microbial metabolites

X

X

X

X

Inflammation/Immunity

X

X

X

X

Liver function

X

X

X

X